The Environmental Protection Agency (EPA) Office of Research and Development has awarded a firm fixed price purchase order contract to Metabolon, Inc., a self-certified small disadvantaged business, for $60,624.00. The contract is for conducting global metabolites analysis on 72 rat serum samples and 72 mouse serum and tissue samples to study hypothalamic pituitary adrenal axis effects. Metabolon has significant experience providing specialized metabolomics analysis services to federal agencies,...
The USDA Agricultural Research Service awarded a $19,260.15 firm fixed price purchase order to Metabolon, Inc. of Morrisville, North Carolina to provide global metabolomics services on fetal liver samples. In response to a pre-solicitation notice seeking information to fulfill requirements for assessing the effects of maternal supplementation on fetal liver metabolism through non-targeted UPLC-MS analysis, Metabolon will deliver sample preparation and multiple mass spectrometry analysis...
The National Institutes of Health's National Institute of Environmental Health Sciences awarded a $25,248 firm fixed price purchase order to Metabolon, Inc. for metabolomics analysis services in support of placode cell differentiation research. As the prime contractor, Metabolon will perform analysis on wild type and SMCHD1KO cells during placode cell development studies. The contract runs from September 1, 2023 through December 31, 2023 with all work conducted by Metabolon at its Morrisville,...
This federal contract was awarded by the National Institutes of Health (NIH), National Cancer Institute, to Metabolon, Inc., a small disadvantaged business provider of metabolomics services and solutions. The $156,520.00 contract is for plasma and urine metabolomic profiling of ultra-processed diets in a randomized controlled trial, and serum metabolomic profiling of hair dye use in the ATBC study. This work supports the agency's Major Program Code for metabolomic profiling in molecular...
Environmental Protection Agency Office of Research and Development awarded a $22,770 firm fixed price purchase order to Experimental Pathology Laboratories, Inc. for a study titled "Maternal and F1 Rat Effects of PFOA Exposure During Pregnancy." The work will be conducted at the awardee's Sterling, Virginia location with completion by December 31, 2024. No set-aside designation was applied. As part of EPA's ongoing research into perfluorooctanoic acid, this contract supports evaluating...
This is a federal contract award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Metabolon, Inc., a self-certified small disadvantaged business, for $21,600.00. The contract is for the acquisition of metabolic profiling of mouse livers. Metabolon is a leading provider of metabolomics solutions, offering advanced analytical methods and software for biomarker discovery in drug development and life sciences research. The company has served as...
This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Metabolon, Inc., a self-certified small disadvantaged business, for the cross-comparison of samples from pediatric patients with Smith-Lemli-Opitz syndrome (SLOS), Niemann-Pick disease (NPC), and Creatine Transporter Deficiency (CTD) using metabolomics analysis. The contract has a total value of $43,450.00 and a period of performance ending on August...
The Environmental Protection Agency (EPA) Office of Research and Development awarded a $25,632.00 firm fixed price purchase order to Metabolon, Inc., a self-certified small disadvantaged business, for metabolomic assessment of mouse serum samples after exposure to produced water. The contract has a completion date of August 30, 2024. This award is not associated with a larger contract vehicle and does not include a set-aside designation. Metabolon has previously supported metabolomics research...
The U.S. Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a $204,715.60 firm-fixed-price purchase order to Charles River Laboratories, Inc. to conduct a non-GLP 50 antisense oligonucleotide (ASO) liver toxicity study in mice. The purpose is to develop a predictive model of candidate ASO therapies' safety and acute toxicity, supporting NCATS' efforts to accelerate the development of effective treatments for...
This contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Metabolon, Inc., a small disadvantaged business, for $212,520.00. The contract is for global untargeted metabolomics analysis of stool and breast milk samples, as well as short-chain fatty acid panel analysis, in support of NIAID's research to identify biomarkers that can predict the development of food allergies in...